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Recently, monoclonal antibodies (MoAb) have been raised 
against a family of adhesive membrane receptors (R) for ex-
tracel lular matrix molecules known as integrins. In order to 
ascertain whether these adhesive proteins are normally ex-
pressed in inherited epidermolysis bullosa (EB) dermal epi-
dermal junction, we studied the reactivity of MoAb recogniz-
ing receptors for VLA-1 (R for unknown ligand), VLA-2 (R 
for collagen), VLA-3 (R for collagen, laminin, li.bronectin), 
VLA-4 (R for unknown ligand), VLA-5 (R for li.bronectin), 
VLA-6 (R for laminin), VNRa, and VNRP (R for vitronec-
tin) on cryostat skin sections from EB patients and normal 
controls and on cytospins of normal epidermal cell suspen-
sions with indirect immunohistochemical methods. Two 
cases of junctional EB (EBj) (lethal and non-lethal), three 
cases of dominant dystrophic EB (EBdd), rwo cases of reces-
E pidermolySIS bullosa (EB) represents an heterogeneous family of hereditary mecbanobullous diseases best classi-fied according to the ultrastructural level of cleavage. In EB simplex the cleavage plane is always imraepidermal. In junctional EB the cleavage occurs through rhe lamina 
Iucida of the epidermal basement membrane zone (BMZ), whereas 
in dystrophic EB it is beneath the lamina densa of the BMZ. Little is 
known about the mechanism of blistering in these disorders. In the 
past few years important insights in the pathogenesis of EB have 
been made by the ultrastructural and immunologic demonstration 
of abnormality ofhe1nidesmosomes in junctional EB and of anchor-
ing fibrils m dystrophic EB, but many different mechanisms may 
play a role [1- 3]. 
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Abbreviations: 
APAAP: alkalme phosphat~e ant1-alkaline phosphatase 
BMZ: basement membrane zone 
BP: bullous pemphtgotd 
EB: eptdermolym bullosa 
EBJ: junctional cpidcnnolys i ~ bullosa 
EBdd: donunant dystrophic epidermolysis bullosa 
EBdr: recessive dystrophic epidermolysis bullosa 
MoAb: monoclonal antibody 
R: receptor 
VLA: very late anngen 
VNR: vitronecrin receptor 
sive dystrophic EB (EBdr), and two normal controls skin 
sections and cell suspensions entered the study. No signifi-
cant modification of the distribution of these adhesive recep-
tors was observed in junctional and dystrophicEB skin. Both 
in normal and EB specimens MoAb against VLA-2, VLA-3, 
and VNRa determinants showed reactivity with the total 
cytoplasmic membrane of basal keratinocytes and basement 
membrane zone. Interestingly, anti-VLA-6 MoAb was char-
acterized by an intense linear staining of the dermal-epider-
mal junction with the same localization on the roof of the 
blisters in EBj, EBdd, and EBdr as bullous pemphigoid (BP) 
serum. On the basis of these results we suggest that anti-
VLA-6 MoAb could be used instead of BP serum for immu-
nohistochemical detection of the cleavage of blisters in EB.J 
Invest Dermato/95:60-64, 1990 
Cell culture studies of normal skin have demonstrated that in 
specialized areas of the plasma membrane serving as attachment sites 
for stress fibers, cell surface receptors establ ish a link between the 
cyro~kcleton , the plasma membrane , and the extracellular matrix , 
involving molecules such as collagen , laminin, and fibronectin [4]. 
These receptors, termed integrins, are a superfamily of heterodi-
meric cell surface receptors consisting of a common ft-chain and 
different a-chains that confer selective affinity toward ligands con-
taining the amino acid sequence Arg-G ly-Asp [5,6]. The integrins 
bind directly to collagen, laminin, and fibronecrin and to the cyto-
skeleton associated protein talin, which in rum is associated with 
actin filaments. Antisera to integrins were shown to block cell adhe-
sion to collagen, fibronectin, and laminin, and it appears that the 
integrins may function borh as a structural link and as sites of com-
munication between rhe cell and the extracellular environment [7). 
Four members of the integrin superfamily exist that are individually 
defined by the type of beta subunit present in the alpha-beta dimer: 
the very late antigens (VLA) proteins [8), the leukocyte adhesion 
proteins (LFA-1, Mac-1 and ~ 150-95) [9], the cytoadhesins (gp 
lib/ lila, vitronectin receytors) [ 1 0], and the recently described 
beta-4 epithelial integrin [11 ]. The VLA family, initially identified 
as late appearing antigens in mitogen stimulated T cells, comprise at 
least six related heterodimers mainly involved in cell interactions 
with molecules such as laminin, collagen, and fibronectin. The 
second family of integrins, defined by a common beta-2 subunit, 
includes the LFA- 1 molecule involved in binding T cells to target 
cells (ICAM-1 +), the Mac-1 and p150-95 monocyte-macrophage 
receptors for complement component C3b which appear important 
in binding of these cells to endothelial cells. The third family of 
integrins comprise the vittonectin receptor and the platelet gp lib/ 
lila complex. Vitronectin is a plasma membrane glycoprotein that is 
important for the attachment and spreading of cells in vitro and 
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presumably 111 v1vo. The platelet mtegrin gp lib/ lila mediates b111d-
ing to fibnnogen, von Willebrand facror, and fibronecun . 
In order to ascerra111 whether the alteration of dermal-ep1dermal 
adhesive properries seen 111 JUnctional and dystroph1c 111hemed EH 
skm could be related to a defect of integrins expressiOn and to 
determine the diagnostic usefulness of antibodies agamst these re-
ceptors, we stud1ed the reacuviry of MoAb directed agamst VLA-1 
-2 -3 -4 -5-6, VLAP. VNRa, and VNRP receptors on frozen skm 
sect1ons from patients affected with junctional and dystrofl11c EB 
and from normal controls and on cytospins preparations o epider-
mal cells suspensiOn w1th indirect immunolustochcmtcal rcch-
mques. 
MATERIALS AND METHODS 
Source of Monoclonal Antibodies The VLA recepror mole-
cules were recogni1ed by TS2/7 (VLA-1 ). Gi 14 (VLA-2). J 143 
(VLA-3), B-SG 10 (VLA-4}, and K20 (VLAP} mouse monoclonal 
antibod1cs, and B I ES (V LA-S) and GO-H3 (VLA-6) rat monoclo-
nal antibody (Table I) . Vitronectin receptors were 1dcnufied by 
13C2 (VNRa) and CLB/Thrl (VNRP} mouse monoclon.1l ann-
bodies. The MoAb TS2/7 was kindly provided by Dr. M. Hemler. 
the MoAb J 143 by Dr. L. Old, and the MoAb B 1 ES by Dr. P. 
B1berfeld. The other MoAb were obtained from the Ill .1nd IV 
International Workshop on Leucocytes D1fferent1ation Anngem 
(Oxford 1986; V1enna 1989}. 
Skin Specimens Exa mined Skin specimens were obtained from 
seven patients with epidermolysis bullosa: two patients With JUnc-
tional EB {non-lethal, one; lethal, one), three patients w1th domi-
nant dystrophic EB, and rwo patients with recessive dystroph1c EB. 
Prior diagnosis was established in each patient on the basis of climcal 
findings, family history, umnunofluorescence mappmg, and elec-
tron microscopy. 
Four-millimeter punch btopsy specimens were obtained from 
clinically normal appearing upper, inner arm skin followmg local 
anesthesia with 2% lidocame from each of these parients. S1milar 
skin specimem were obtained from two normal adult mdiv1duals 
and served as control tissue. 
Each specimen was embedded in OCT compound, map frozen 111 
liqUid nitrogen, and stored at -70"C. 
E pidermal C e ll Suspension Normal human sk111 obta111ed 
from surg1cal spec1mens was split cut with a keratotome. The re-
sulting sheets were transferred to sterile petri d1shes, and incubated 
at 37"C for 1 h with 0.25% trypsin (Gibco Ltd., Scotland) m phos-
phate-buffered saline (PBS} without calcium and magne\IUm \alts. 
The ep1dermis was then separated from the dermis usmg fine for-
ceps. The Isolated ep1dermal samples were placed in RPM! 1640 
mediUm {G1bco) supplemented with lOo/o fetal calf serum (Flow 
Table I. Summary of the Integrins Receptors Exammed 
Receptor MW(kDa)• CD' Subumts Ligands MoAh 
VLA-1 210/130 49a et1/P1 ?' TS2/7 
VLA-2 165/ 130 49b et2/P1 coiiJ(t-IV) Gil4 
VLA-3 135-25/ 130 49c et3/P1 coii,LM,FN J143 
VLA-4 80+70/130 49d et4/Pl HR?' B-SGIO 
VLA-5 140+25/ 130 49c et5/P1 FNI HIES 
VLA-6 120+30/130 49( et6/Pt LMl G0-113 
VLAP 130 29 p K20 
VNRet 125+25 51 etV //13 VN4 13C2 
VNR/1 114 61 {13 CLH/Thrl 
• MW molrculu we1ghr. 
'CD: cluster defined at the IV International Workshop on Ltucocyt~ D1fl"ere111a-
non Anugrru (V1enna 1989). 
• ?: unknown. 
J coli: collagen 
' II R: homing receptor 
I FN: libronectm. 
t LM: lamuun. 
'VN' vmonrctm. 
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Lab. Ltd., Scotland), p1perred v1gorously. and then s1eved through 
stenle nylon gauze to obtall1 a \mgl{"-cell susp{"mlon. Cytospms 
wer{" obtained using a Shandon cytocenrrifuge. 
lrnmunostai oing An md1rect Immunofluorescence and alkaline 
phmphata~e anti-alkaline phosphatase (APAAP) method was per-
formed on specimens of skm from EB panents and normal conrrols 
and on ep1dermal cell suspens1on cyrospms. Five-micrometer th1ck 
cryostat skm sections, prepared from each nssue specunen, were 
placed on clean glas~ slides, dned overnight at room temperature, 
and acetone fixed for I 0 m1n. The ,II des were then nnsed m 0.05 M 
Tris-buffered saline pH 7.6 (TBS) for I 0 mm and subsequently 
mcubated for 10 min with TBS plus I 0% normal human AB serum 
and I 0% normal rabbit serum, and for 60 min with MoAb diluted 
1/400 in TBS, BSA 1%, Na azide 0.1%, at room temperature 
withm a humidified chamber. Then, for ind1rect immunofluores-
cence, the slides were rinsed I 0 111111 111 TBS and then mcubated for 
60 min with fluorescein-conjugated F(ab')2 fragments of rabbit lgG 
to mouse I gG (H + L) diluted I : 30 111 TBS, BSA 1%, Na azide 
0.1 O!o (Dako Glostrup. Denmark; known to also react with rat lgG}. 
Followmg two further washings 111 TBS, the shdes were mounted 
w1th 50% glycerolm PBS and exammed usmg a fluorescence mi-
croscope. 
After mcubation with MoAb. APAAP method was performed 
accordmg to standard procedure [ 12] us111g Dako rea gems. Immu-
nologic reaction was revealed usmg New-Fuchsin, naftol AS-BI 
phosphate sodium salt, and 1 mM levam1sole {SIGMA Chemicals, 
Samt Louis, MO) for 20 mm at room temperature. Samples were 
finally counterstained With Mayer hematoxyl111e (10 s) and ob-
served With a light microscope. 
Im m unofluorescence Double Labeling (Bullous Pemphi-
goid Human Serum a nd a oti-VLA-6 MoAb) Cytospins of 
ep1dermal cell suspensions, dned and fixed as previomly described 
for cryostat sections, were rinsed 10 min 111 TBS, mcubated for 10 
min w1th normal goar serum 20o/o in THS and chen simultaneously 
for 60 min with human bullous pemphig01d serum (diluted 1 : 5 in 
TBS) and anti-VLA-6 MoAb. The slides were then rinsed in TBS 
for I 0 min and 111cubared for 60 111111 With a m1xture of fluorescein-
conjugated F(ab')2 fragment\ of rabb1t lgG ro human lgG (H + L) 
(Dako) and ofTRICT-conJugared F{ab')2 fragments of goat lgG to 
mouse lgG (H + L) (Techno Grnwcs M.Jan, Italy; known to also 
react With rat IgG). both diluted I :50 111 TBS, BSA 1%, Na azide 
0.1 °1o. Cytospins were then rimed m TBS (I 0 mm X 2) and 
mounted 111 glycerol-PBS soluuon. 
Immunofluorescenc e D o uble Labeling (MoAb to lntegrins 
R ecepto rs and OKT6 MoAb) Cytospins or cryostat sections, 
prepared as cited above, were nmed 111 TBS for 10 m111 and mcu-
bJted subsequently With normal human serum AB and normal goat 
serum I Oo/o in TBS for 10 mm, with different MoAb anti-VLA and 
anti-VNR for 60 min, With TRICT-conjugated F(ab'}2 fragments 
of goat lgG to mouse lgG (diluted 1 :50) for 60 min, with normal 
ascites {1 :400 diluted in TBS) for 30 min and with FITC-conju-
gated OKT6 {ami-COla} (Ortho Diagnostic, Raritan, NJ) diluted 
1 :30 in TBS, BSA 1%, Na azide 0. 1 %. After each incubation the 
slides were rinsed for 10 min m TBS. Fmally the slides were 
mounted in PBS-glycerol solution and observed at the fluorescence 
nucroscope. 
RESULTS 
Results of tissue sections stud1es are listed in Table 11. As is apparent 
from such data there is no significant vanabl11ry of expression of the 
anngens examined in clinically uninvolved skin from patients with 
junctional and dystrophic EB and in control human skin. In each of 
the specimens analyzed, MoAb against VLA-2, VLA-3, and VNRa 
receptors showed a significant reactivity with cytoplasmic mem-
branes of basal keratmocytcs, sebocyres, eccrine basal cells, and fol-
licular basal cells {Figs 1- 3). Weak linear seaming of the basement 
membrane zone (BMZ) was observed with anti-VLA-2, anti-VLA-
3, and anti-VNRa. 
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Table II. Expression of lnregrins at Dennal-Eptderrnal Junction in C linically U ninvolved Skm from Patients with Epidermolysis 
Bullosa (EB) 
Junctional Lethal (#I) 
Junctional Non-Lethal (#2) 
Dystrophtc, Dommant (#4,5) 
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• BK: basal ker;uinocytes. 
1 BMZ: basemrnr membnne zone. 
'+: strong, connnuous reacnvuy. 
1 ±: dtsconrinuous reactivity. 
' t: weak conunuous reacrivtn·. 
In those specimens in wluch dennal-eptderrnal separation result-
ing from the trauma of biopsy could be detected (one case each for 
EBj, EBdd, and EBdr), the staining with anti-VLA-2, 3 and anti-
VNRa: was mainly localized on baJ.al keratinocytes at the roof of the 
blister. A lmear thin labeling at the bottom of the cavity was seen in 
EBj (Fig 2), while no labelmg was detected in the same area 111 EBdd 
and EBdr (Fig 3). 
The anri-VLA-6 MoAb was characterized by a continuous linear 
intense seaming of the BMZ along epidermis, hair follicles, and 
papillary vessels (Figs 4 and 5). Using the more senSitive APAAP 
method, anti-VLA-6 also stained the cytoplasmic membranes of 
basal keratinocytes, sebocytes, eccrine basal cells, and follicular basal 
cells. In the cases in which dermal-epidermal separation occurred, 
anti-VLA-6 MoAb was always seen solely along the eptdennaJ side 
of the blisters (Fig 5); no staining was noted on the dermal portion 
of the blisters. 
SuprabasaJ cells were nor or oniy weakly stamed by any of the 
above-mentioned MoAb. Antibodies against VLA-1, VLA-4, 
VLA-5, and VNR{J receptors showed no reactivity wtth keratmo-
cytes or BMZ in EB and normal controls spec•mens; MoAb anti-
VLA-1 stained endothelial cells of capillary vessels and MoAb anti-
VLA-4 labeled dermallympho-monocytic cells and intraepidermaJ 
Langerhans cells (data confirmed usmg double labelmg techniques 
with OKT6-FITC on skin secuons and cytospms preparations). 
Figure 1. Jndtrect immunofluore~cence usmg :mri-VLA-3 monoclonal an-
tibody on normal control skm showmg reacttvtry with the cytoplasmic 
membrane of basal kerarinocyrcs and basement membrane zone. 
Anu-VLAP MoAb markedly stained all the specimens tested, with a 
label ing pa ttern that seemed ro include the reactivities observed 
with anti-VLA-2 and anti-VLA-3. 
On epidermal cell suspensions cytospins, double labelmg 
methods using anti-VLA MoAb, and BP serum clearly demon-
mated that the cytoplasmic membrane of BP positive cells (basal 
keradnocytes) stain with anti-V LA-2,3,6 and anti-VLAP MoAb. 
Antt-VLA-6 MoAb showed a distinct polar cap of fluorescence m 
t he same side (Fig 6) stained by the BP serum. 
DISCUSSION 
T he recent Identification of some of the antigenic determinants 
present at the dermal-epidermal JUnction proved to be important for 
the diagnosis of rhe mherited mechanobullous disorders ll). A map-
ping of the distribution of these antigens within the bl ister area, 111 
fact, can be useful to determine the sire of cleavage which is the 
single most •mportanc diagnostic cmenon [2). In addition, the dem-
onstration that a few of the recognized antigenic epitopes tn normal 
dermal-epidermal junction are constantly absent or reduced in ex-
pression in specific types of inherited epidermolysis bullosa may 
prove essential for the identification of new diagnostic probes and 
for elucidating the pathogenesis of these diseases [3,13-16]. 
In this study, we have described the reactivity of a panel of specific 
antibodies, recognizing multiple adhesive protein receptors, local-
Figure 2. Indirect tmmunofluorescence usmg anti-VLA-2 monoclonal an-
tibody on skm from patient wtth JUnctional eptdermolySIS bullosa (non-
lethal) showmg reactivity wirh cell membranes of basal kerarinocytes on rhe 
top of bltstcr. 
' 
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Figure 3. lnd1rect lmmunofluorescc.-ncc.- usin~ ano-VLA-3 monoclo!Ul an-
ubody on skm from patient with rec~ive dy~uophic epidermolym bullos~. 
The srammg was localized on bas~l kerJtinocyres ;u the roof of the bhster. 
Figure 4. lnd1rect immunolluore•cence usmg anu-VLA-6 monoclonal :an-
tibody on skm from patient with dommant dysrroph1c ep1dermolym bullosa 
showmg I. near conrinuou.o. labeling of b~ement membrane zone and reac-
tiYiry with pap1llar)' vessels. 
FigureS. Indirect unmunolluorescence usmg.mri-VLA-6 monoclonal an-
ubody on 1km from patient with JUnctional ep1dennolym bullosa (non-
lethal) showmg dccccnon solely on the top of the blim:r. 
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Figure 6. Indirect 1mmunoAuorescence using ;rno-VLA-6 monoclonal an-
tibody on epidermal cell suspensions cytmpins showmg a polar cap of fluo-
rescence. 
ized at the dcm1al-epidermal iO[erface, in Junctional and dystrophic 
EB skin as well as m normal controls skin, and on cytospins prepara-
tions of normal epidermal cell suspensions. No 5ignilicant modifi-
cation of mulople adhesive protein receptors in temu of distribution 
and expression could be detected in EB skm in companson with 
normal controls skin. The MoAb against VLA-2, mvolved in bind-
ing cells to type I, Ill, and rv collagen (17), and che anti-VLA-3 
MoAb, a mulmpecific cell adhesion receptor for type I and Ill colla-
gen, fibronectin, and lammm(18), always showed a strong seaming 
of the basal keratmocytcs. Anci-VLA-6, a lanunm receptor [ 19], on 
che other band, bas shown intense continuous linear staining along 
che dermal-ep1dermal junction and a weak reactivity wich basal 
kerat111ocytes. Data obt4.ined in bhscer areas of EBdd, EBdr, and EBJ, 
and on normal epidemul cell suspensions cyto~p1ns, showed rhat 
anti-VLA-6 MoAb reactiVIty had similar distribution of bullous 
pemphigo1d serum. 
Recent reports md1cated that the" bullous pemph1g01d anugen IS 
not expressed 111 a reproduc1ble manner in skin from patients wirh 
some forms ofEB, rhus rcscncttng the u~efulness of the correspond-
ing antibodic~ 111 diagno~tic immunofluorescence mapping studies 
[20). In add1rion, most of che currently utilized antibodies to bullous 
pemphigoid, because of polyclonal ongin. vary specifically 111 spe-
cific antibody content. 
When compared w1rh immunofluorescence seaming observed 
usmg the polyclonal bullous pemphigoid 5erum antibodies on msue 
secnons, the anti-VLA-6 was expressed m a more untform andre-
producible manner, both 111 normal sk.m and 111 EBJ. EBdd, and 
EBdr, where It labeled the undersurface of basal keracinocytes with-
out cross-reactiv1ry w1th other ti\sue components of rhe basement 
membrane zone. These findmgs suggest that ant1-VLA-6 monoclo-
nal anubody, 111 irs potentially unlimited supply, may serve as an 
excellent substitute for currently unhzed polyclonal bullom pem-
ph1go1d serum 111 d1agnomc Immunofluorescence mappmg studies. 
Tht twtfrors xratifully aclmoul/t>dR" Dr. M Hrml~r (Daua Farb~r Caucn lmtrtutt, 
Han•ord Medical School, Bostou, MA) J.~r pr<ll'idw.~ tht VLA-1 Mc.1Ab, Dr L. Old 
(Sh•au Ktttrriu.~ Momma/ Ht>.Spltal, N\')jor providing tht VLA-J MoAb, aud Dr 
P. Bibrrftld (Karolmska Ttl511tutt, St,•rkl•olm, S1wdm) fi~r pro1•rdiug tlrt VLA-5 
MoAb 
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ANNOUNCEMENT 
The Assoc1ation for Psychocutaneous Medlcmc of Nonh America (APMNA) seeks mtere~ted 
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Med1c1ne of North Amenca (APMNA) w,1s hdd in Dall<e>, Texas, amacung pamcipants from 
aao~' the Umted Stares and Canada. The pnmary purpose of rhe orgamzation is co provide a 
fon1m for the exchange of 1deas and mformanon amongst the workers m th1s area of med1cine. 
Th1s assoCiauon 1s intended pmnanly for profemonals res1ding and pracncmg 111 North Amer-
ica. 1.c. Canada, U.S.A., and Mex1co. Membersh1p IS open to fully qualified phys1c1ans who are 
board certified or eligible 111 dermatology. psychiatry. and/or psychoanalysis and to Ph.D. 
psychologists. Professionals m health fields not covered by these categories, or profemonals not 
srricdv 111 the hcalthcare field, may applv for assoc1ate or affiliate membersh1ps. Membership 
informanon may be obtained by wnung to APMNA, 1812 Delancey Place, Ph.ladelph1a, PA 
19103. 
